|
|
Vitamin B6 | |
| Side effect reduction/prevention |
None known |
| Supportive interaction |
None known |
| Reduced drug absorption/bioavailability |
None known |
| Adverse interaction |
None known |
An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.
Vitamin B6
Levodopa is broken down in the body by a process requiring vitamin B6. Breakdown may deplete
available vitamin B6. Carbidopa blocks levodopa breakdown
and prevents vitamin B6 depletion. People taking
levodopa/carbidopa (Sinemet®), or levodopa plus carbidopa (Lodosyn®) have no
risk for levodopa-induced vitamin B6 deficiency; it is not a problem for people to supplement
vitamin B6 while taking Sinemet.
For people taking levodopa alone, small amounts of vitamin B6 (5–10 mg per day) may prevent levodopa-induced vitamin B6 deficiency.1 Amounts of vitamin B6 slightly higher than those required to replace depleted levels, may reduce the effectiveness of levodopa therapy and should not be taken.2
Food
Food, especially foods high in protein, compete with levodopa for absorption. However,
levodopa may be taken with food to avoid stomach upset.3 It is important to take
levodopa at the same time every day, always with or always without food. People with questions
about levodopa and food should ask their prescribing doctor or pharmacist. Taking
sustained-release Sinemet® CR with food may
increase blood levels of levodopa.4 It is important to take Sinemet® CR at the
same time every day, always with or always without food. People with questions about
Sinemet® CR and food should ask their prescribing doctor or pharmacist.
1. Long JW. The Essential Guide to Prescription Drugs 1992. New York: Harper Perennial, 1991.
2. Trovato A et al. Drug-nutrient interactions. Am Family Phys 1991;44:1651–8.
3. Threlkeld DS, ed. Central Nervous System Drugs, Antiparkinson Agents, Levodopa. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Sep 1991, 289p–290a.
4. Threlkeld DS, ed. Central Nervous System Drugs, Antiparkinson Agents, Levodopa. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Sep 1991, 289p–290a.
| |||||||